Uploaded July 2026 | Updated September 2026, 3 weeks ago
Advanced prostate cancer treatment has changed significantly in the past decade. Advances in treatment are helping many patients live longer, stay active, and maintain a high quality of life. In this video, experts from Mayo Clinic Comprehensive Cancer Center in Rochester, Minnesota, explain how innovations such as theranostics and multidisciplinary cancer care are changing what's possible for people living with advanced and metastatic prostate cancer.
Theranostics is an emerging field of nuclear medicine that combines advanced molecular imaging with targeted radiopharmaceutical therapy. This approach helps clinicians identify cancer cells and deliver treatment directly to them while minimizing damage to healthy tissue. Mayo Clinic specialists discuss how theranostics, personalized treatment planning, and close collaboration among oncologists, radiologists, and researchers are transforming care for patients with advanced and metastatic prostate cancer.
Learn more or request an appointment: mayoclinic.org/diseases-conditions/metastatic-prostate-cancer/care-at-mayo-clinic/mac-20377978
You'll learn:
• How advanced prostate cancer is treated today
• What theranostics is and how it works
• How molecular imaging helps guide treatment decisions
• Why multidisciplinary cancer care improves patient outcomes
• How personalized treatment plans adapt as a patient's needs change
• Why many patients with advanced prostate cancer are living longer than ever before
Questions answered in this video:
• Is advanced prostate cancer treatable?
• What is theranostics for prostate cancer?
• How does radiopharmaceutical therapy target cancer cells?
• What is multidisciplinary cancer care?
• How does personalized medicine improve treatment planning?
Featuring Mayo Clinic Experts:
• Dan Childs, M.D. – Genitourinary Medical Oncologist
• Elisabeth Heath, M.D. – Chair, Department of Oncology
• Jacob Orme, M.D., Ph.D. – Genitourinary Medical Oncologist and Translational Scientist
• Geoffrey Johnson, M.D., Ph.D. – Chair, Radiopharmaceutical Trial Team
About Mayo Clinic Comprehensive Cancer Center
Mayo Clinic Comprehensive Cancer Center brings together specialists across oncology, radiology, nuclear medicine, surgery, and research to develop individualized treatment strategies for patients with complex cancers, including advanced and metastatic prostate cancer.
MayoClinic Patient Stories & Resources: https://mcpress.mayoclinic.org/advanced-prostate-cancer/the-mayo-clinic-way-of-advanced-prostate-can...
#ProstateCancer #MetastaticProstateCancer #Theranostics #CancerTreatment #MayoClinic
From Mayo Clinic to your inbox (free):
mayocl.in/3e71zfi
Visit Mayo Clinic:
mayocl.in/2COVmlm
Connect with Mayo Clinic:
Facebook: facebook.com/mayoclinic
Instagram: instagram.com/mayoclinic
X: https://x.com/MayoClinic
Threads: threads.net/@mayoclinic
Advanced prostate cancer treatment has changed significantly in the past decade. Advances in treatment are helping many patients live longer, stay active, and maintain a high quality of life. In this video, experts from Mayo Clinic Comprehensive Cancer Center in Rochester, Minnesota, explain how innovations such as theranostics and multidisciplinary cancer care are changing what's possible for people living with advanced and metastatic prostate cancer.
Theranostics is an emerging field of nuclear medicine that combines advanced molecular imaging with targeted radiopharmaceutical therapy. This approach helps clinicians identify cancer cells and deliver treatment directly to them while minimizing damage to healthy tissue. Mayo Clinic specialists discuss how theranostics, personalized treatment planning, and close collaboration among oncologists, radiologists, and researchers are transforming care for patients with advanced and metastatic prostate cancer.
Learn more or request an appointment: mayoclinic.org/diseases-conditions/metastatic-prostate-cancer/care-at-mayo-clinic/mac-20377978
You'll learn:
• How advanced prostate cancer is treated today
• What theranostics is and how it works
• How molecular imaging helps guide treatment decisions
• Why multidisciplinary cancer care improves patient outcomes
• How personalized treatment plans adapt as a patient's needs change
• Why many patients with advanced prostate cancer are living longer than ever before
Questions answered in this video:
• Is advanced prostate cancer treatable?
• What is theranostics for prostate cancer?
• How does radiopharmaceutical therapy target cancer cells?
• What is multidisciplinary cancer care?
• How does personalized medicine improve treatment planning?
Featuring Mayo Clinic Experts:
• Dan Childs, M.D. – Genitourinary Medical Oncologist
• Elisabeth Heath, M.D. – Chair, Department of Oncology
• Jacob Orme, M.D., Ph.D. – Genitourinary Medical Oncologist and Translational Scientist
• Geoffrey Johnson, M.D., Ph.D. – Chair, Radiopharmaceutical Trial Team
About Mayo Clinic Comprehensive Cancer Center
Mayo Clinic Comprehensive Cancer Center brings together specialists across oncology, radiology, nuclear medicine, surgery, and research to develop individualized treatment strategies for patients with complex cancers, including advanced and metastatic prostate cancer.
MayoClinic Patient Stories & Resources: https://mcpress.mayoclinic.org/advanced-prostate-cancer/the-mayo-clinic-way-of-advanced-prostate-can...
#ProstateCancer #MetastaticProstateCancer #Theranostics #CancerTreatment #MayoClinic
From Mayo Clinic to your inbox (free):
mayocl.in/3e71zfi
Visit Mayo Clinic:
mayocl.in/2COVmlm
Connect with Mayo Clinic:
Facebook: facebook.com/mayoclinic
Instagram: instagram.com/mayoclinic
X: https://x.com/MayoClinic
Threads: threads.net/@mayoclinic
